BlackRock »

Enanta Pharmaceuticals shares owned by BlackRock

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by BlackRock

Quarter filed Position value Share count Share price at filing
2024-12-31 $12M 2.0M 5.75
2024-09-30 $20M 1.9M 10.36

More positions owned by BlackRock

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Mastercard Incorporated Cl A (MA)

View all positions for BlackRock

Top funds holding Enanta Pharmaceuticals

Farallon Capital Management
BlackRock
Vanguard Group
Krensavage Asset Management
Morgan Stanley
RA Capital Management
Marshall Wace
Millennium Management
Acadian Asset Management
Renaissance Technologies
Geode Capital Management
State Street Corporation
D. E. Shaw & Co
Northern Trust
Stonepine Capital Management

View all funds holding Enanta Pharmaceuticals